The CHMP renders a positive opinion recommending approval for MRK's Keytruda for the first-line treatment of malignant ...

The CHMP's opinion is based on late-stage study data, which show that treatment with JNJ's combo drug reduces the risk of ...

AstraZeneca’s Tagrisso (osimertinib) has been recommended for approval in the EU for treating adult patients with ...

Catumaxomab received a positive opinion from the EMA's Committee for Medicinal Products for Human Use (CHMP) at its October 2024 meeting and if approved catumaxomab will be the only approved drug for ...

We're looking to change that through this partnership with Lindis Biotech, reintroducing catumaxomab to the market, subject to full regulatory approval ... Committee for Medicinal Products for Human ...

Catumaxomab received a positive opinion from the EMA's Committee for Medicinal Products for Human Use (CHMP) at its October 2024 meeting ... subject to full regulatory approval. We're excited to put ...

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA ... Stage III EGFRm NSCLC in the US. Regulatory applications are also currently under review in China, ...

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA ... Stage III EGFRm NSCLC in ...